+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Pharmaceutical Analytical Testing Outsourcing Market by Product (Active Pharmaceutical Ingredients, Additives, Finished Product), Service (Bioanalytical Testing, Method Development & Validation, Stability Testing), Application, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454989
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pharmaceutical Analytical Testing Outsourcing Market size was estimated at USD 8.52 billion in 2023, USD 9.32 billion in 2024, and is expected to grow at a CAGR of 9.45% to reach USD 16.03 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Analytical Testing Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Analytical Testing Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Aztech Sciences Inc., Boston Analytical, Inc., Cambrex Corporation, Catalent, Inc, Eurofins Scientific SE, Exova Group PLC, Merck KGaA, Pace Analytical Services, Inc., Recro Gainesville, SEIKAGAKU CORPORATION, SGS SA, and Source BioScience.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Active Pharmaceutical Ingredients
    • Additives
    • Finished Product
    • Raw Materials
  • Service
    • Bioanalytical Testing
      • Clinical
      • Non-Clinical
    • Method Development & Validation
      • Extractable & Leachable
      • Impurity Method
      • Technical Consulting
    • Stability Testing
      • Accelerated Stability Testing
      • Drug Substance
      • Photostability Testing
      • Stability Indicating Method Validation
  • Application
    • Bio Analytical Testing
    • Method Development & Validation
    • Stability Testing
  • End-Users
    • Biopharmaceuticals
    • Contract Manufacturing organizations
    • Pharmaceuticals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pharmaceutical Analytical Testing Outsourcing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Analytical Testing Outsourcing Market?
  3. What are the technology trends and regulatory frameworks in the Pharmaceutical Analytical Testing Outsourcing Market?
  4. What is the market share of the leading vendors in the Pharmaceutical Analytical Testing Outsourcing Market?
  5. Which modes and strategic moves are suitable for entering the Pharmaceutical Analytical Testing Outsourcing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Analytical Testing Outsourcing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing research and development in drug discovery and development
5.1.1.2. Rising incidence of cancer and other infectious diseases worldwide
5.1.1.3. Increasing investments in the pharmaceutical industry
5.1.2. Restraints
5.1.2.1. Relatively high cost involved in drug development
5.1.3. Opportunities
5.1.3.1. Emerging technological advancements in testing procedures for drug development
5.1.3.2. Growing demand of regulatory bodies for analytical details on drugs
5.1.4. Challenges
5.1.4.1. Lack of consistency in the product quality
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharmaceutical Analytical Testing Outsourcing Market, by Product
6.1. Introduction
6.2. Active Pharmaceutical Ingredients
6.3. Additives
6.4. Finished Product
6.5. Raw Materials
7. Pharmaceutical Analytical Testing Outsourcing Market, by Service
7.1. Introduction
7.2. Bioanalytical Testing
7.3.1. Clinical
7.3.2. Non-Clinical
7.3. Method Development & Validation
7.4.1. Extractable & Leachable
7.4.2. Impurity Method
7.4.3. Technical Consulting
7.4. Stability Testing
7.5.1. Accelerated Stability Testing
7.5.2. Drug Substance
7.5.3. Photostability Testing
7.5.4. Stability Indicating Method Validation
8. Pharmaceutical Analytical Testing Outsourcing Market, by Application
8.1. Introduction
8.2. Bio Analytical Testing
8.3. Method Development & Validation
8.4. Stability Testing
9. Pharmaceutical Analytical Testing Outsourcing Market, by End-Users
9.1. Introduction
9.2. Biopharmaceuticals
9.3. Contract Manufacturing organizations
9.4. Pharmaceuticals
10. Americas Pharmaceutical Analytical Testing Outsourcing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Ajinomoto Bio-Pharma
14.1.2. Alcami Corporation
14.1.3. AptarGroup, Inc.
14.1.4. Aztech Sciences Inc.
14.1.5. Boston Analytical, Inc.
14.1.6. Cambrex Corporation
14.1.7. Catalent, Inc
14.1.8. Eurofins Scientific SE
14.1.9. Exova Group PLC
14.1.10. Merck KGaA
14.1.11. Pace Analytical Services, Inc.
14.1.12. Recro Gainesville
14.1.13. SEIKAGAKU CORPORATION
14.1.14. SGS SA
14.1.15. Source BioScience
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
FIGURE 7. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 10. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 11. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 13. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 17. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 22. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 31. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 58. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 59. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 61. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 95. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 96. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 98. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 100. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 102. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 103. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 105. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 116. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 117. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 119. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 156. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 158. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 159. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 161. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 181. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 183. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 187. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 188. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 190. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 192. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 195. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 197. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 201. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 202. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 204. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 206. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 209. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 211. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 220. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 222. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 223. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 225. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 241. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 244. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 246. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 248. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 250. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 251. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 253. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 255. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 257. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 258. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 260. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

  • Ajinomoto Bio-Pharma
  • Alcami Corporation
  • AptarGroup, Inc.
  • Aztech Sciences Inc.
  • Boston Analytical, Inc.
  • Cambrex Corporation
  • Catalent, Inc
  • Eurofins Scientific SE
  • Exova Group PLC
  • Merck KGaA
  • Pace Analytical Services, Inc.
  • Recro Gainesville
  • SEIKAGAKU CORPORATION
  • SGS SA
  • Source BioScience

Methodology

Loading
LOADING...

Table Information